Arpita Kulshrestha Selected Research

Arpita Kulshrestha Research Topics

Disease

14	Neoplasms (Cancer) 10/2020 - 02/2015
6	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
5	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 02/2015
5	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2015
4	Visceral Leishmaniasis (Kala Azar) 12/2018 - 01/2012
2	Inflammation (Inflammations) 01/2016 - 10/2015
2	Premature Obstetric Labor (Premature Labor) 01/2016 - 10/2015
2	Carcinoma (Carcinomatosis) 01/2016 - 02/2015
2	Leishmaniasis 02/2013 - 01/2012
1	Carcinogenesis 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Shock 07/2012
1	Infections 03/2012

Drug/Important Bio-Agent (IBA)

10	Adenosine Triphosphatases (ATPase)IBA 10/2020 - 02/2015
8	Protein Isoforms (Isoforms)IBA 10/2020 - 02/2015
6	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 09/2018 - 02/2015
4	Proton Pumps (Proton Pump)IBA 10/2020 - 02/2015
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2012
3	miltefosine (Impavido)IBA 12/2018 - 01/2012
3	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 12/2018 - 01/2012
2	Peptides (Polypeptides)IBA 01/2020 - 11/2016
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2016
2	PlatinumIBA 01/2019 - 01/2016
2	Jagged-1 ProteinIBA 01/2016 - 10/2015
2	LigandsIBA 01/2016 - 10/2015
2	delta proteinIBA 01/2016 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2015
2	Notch ReceptorsIBA 01/2016 - 10/2015
1	Protons (Proton)IBA 10/2020
1	Caspase 3 (Caspase-3)IBA 10/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	InterleukinsIBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Therapeutic UsesIBA 09/2017
1	BenzopyransIBA 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 11/2016
1	Mifepristone (RU 486)FDA Link 01/2016
1	Platinum Compounds (Compounds, Platinum)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Interleukin-10 (Interleukin 10)IBA 10/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2015
1	Cytidine Monophosphate (CMP)IBA 10/2015
1	Peptidoglycan (Murein)IBA 10/2015
1	Poly I-CIBA 10/2015
1	Actins (F Actin)IBA 02/2015
1	Peptide Hydrolases (Proteases)FDA Link 02/2015
1	CortactinIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Matrix Metalloproteinases (MMPs)IBA 02/2015
1	Histones (Histone)IBA 07/2012
1	Glutamate-Cysteine LigaseIBA 07/2012
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 07/2012
1	ProteomeIBA 07/2012
1	AntimonyIBA 07/2012
1	Staphylococcal Protein A (Protein A)IBA 07/2012
1	AntigensIBA 03/2012

Therapy/Procedure

7	Therapeutics 01/2020 - 01/2012
1	Treatment Delay 10/2020
1	Immunotherapy 10/2020
1	Subcutaneous Injections 01/2016